Various alphabetized medical records

Life Sciences Commercial Disputes

New product introductions in the life sciences sector are frequently complex, costly, and time-consuming undertakings, and collaborations between companies are common. Disputes may arise at all stages of development and commercialization. Our expertise helps clients navigate litigated and arbitrated disputes involving drug development and commercialization and analyze relevant commercial factors (size of the opportunity, therapeutic area, business risks, etc.). CRA has provided expert reports and testimony evaluating development and commercialization efforts and assessing damages associated with alleged contractual breaches and other commercial issues.

Our focus areas


  • 01
    CRA analyses aid settlement negotiation in breach of contract dispute
    CRA was retained by the claimant in a JAMS arbitration regarding a breach of contract dispute in connection with an oncology product. CRA’s team assisted...
    View engagement
  • 02
    Commercial success of pre-operative skin sterilization products
    CRA was retained by the petitioner in an IPR proceeding at the Patent Trial and Appeal Board (PTAB) to determine whether there was evidence of commercial...
    View engagement
  • 03
    CRA consultants calculate damages in a false advertising matter under the Lanham Act
    CRA was retained by counsel for the plaintiff, a manufacturer of medical apparel, to determine damages relating to a false advertising matter under the Lanham...
    View engagement

Subscribe to recieve our latest Insights.